One COVID Vaccine Held Up Best Over Time, CDC Study Suggests In terms of preventing COVID-related hospitalizations, the two-dose mRNA vaccines from Pfizer (Comirnaty) and Moderna offered the best protection upfront and over time, a case-control analysis involving data from 21 U.S. hospitals showed. […]
Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization […]
A combination of MSD’s anti-PD-1 therapy Keytruda (pembrolizumab) and Pfizer’s tyrosine kinase inhibitor Inlyta (axitinib) has been found to reduce risk of death by nearly half compared to sunitinib as first-line treatment for advanced renal cell carcinoma (RCC). The results are taken from the pivotal Phase III KEYNOTE-426 trial, and show that the combination is […]